Sandbox: ay: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 28: Line 28:
{| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; background: #f9f9f9; border: 1px #aaa solid; border-collapse: collapse;
{| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; background: #f9f9f9; border: 1px #aaa solid; border-collapse: collapse;
! colspan="2" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF| '''Disease'''}}
! colspan="2" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF| '''Disease'''}}
!colspan="1" style="background: #4479BA; text-align: center;" | {{fontcolor|#FFF| '''Findings'''}}
! colspan="1" style="background: #4479BA; text-align: center;" | Prominent clinical findings
!Lab tests
!Tratment
|-
|-
| rowspan="3" |'''[[Primary peritonitis]]'''
| rowspan="3" |'''[[Primary peritonitis]]'''
Line 35: Line 37:
* Absence of GI [[perforation]], most closely associated with [[cirrhosis]] and advanced liver disease.  
* Absence of GI [[perforation]], most closely associated with [[cirrhosis]] and advanced liver disease.  
* Presents with abrupt onset of [[fever]], [[abdominal pain]], [[distension]], and [[rebound tenderness]].  
* Presents with abrupt onset of [[fever]], [[abdominal pain]], [[distension]], and [[rebound tenderness]].  
|
* Most have clinical and biochemical manifestations of advanced [[cirrhosis]] or [[nephrosis]] like [[leukocytosis]],[[hypoalbuminemia]],  
* Most have clinical and biochemical manifestations of advanced [[cirrhosis]] or [[nephrosis]] like [[leukocytosis]],[[hypoalbuminemia]],  
* a prolonged [[prothrombin]] time. SAAG >1.1 g/dL, ↑s.lactic acid level, or a ↓ascitic fluid pH (< 7.31) supports the diagnosis. Gram staining reveals bacteria in only 25% of cases.
* a prolonged [[prothrombin]] time. SAAG >1.1 g/dL, ↑s.lactic acid level, or a ↓ascitic fluid pH (< 7.31) supports the diagnosis. Gram staining reveals bacteria in only 25% of cases.
* Diagnosed by analysis of the ascitic fluid which reveals [[WBC]] > 500/ML, and [[PMN]] >250cells/ml.  
* Diagnosed by analysis of the ascitic fluid which reveals [[WBC]] > 500/ML, and [[PMN]] >250cells/ml.  
* Culture of ascitic fluid inoculated immediately into [[blood culture]] media at the bedside usually reveals a single [[enteric]] organism, most commonly ''[[Escherichia coli]]'', ''[[Klebsiella]]'', or [[streptococci]].  
* Culture of ascitic fluid inoculated immediately into [[blood culture]] media at the bedside usually reveals a single [[enteric]] organism, most commonly ''[[Escherichia coli]]'', ''[[Klebsiella]]'', or [[streptococci]].  
|
* Once diagnosed,it is treated with [[Ceftriaxone]].
* Once diagnosed,it is treated with [[Ceftriaxone]].
|-
|-
Line 45: Line 49:
* Seen in 0.5% of new cases of [[tuberculosis]] particularly in young women in endemic areas as a primary infection.
* Seen in 0.5% of new cases of [[tuberculosis]] particularly in young women in endemic areas as a primary infection.
* Presents with [[abdominal pain]] and [[distension]], [[fever]], [[night sweats]], [[weight loss]], and altered bowel habits.  
* Presents with [[abdominal pain]] and [[distension]], [[fever]], [[night sweats]], [[weight loss]], and altered bowel habits.  
|
* [[Ascites]] is present in about half of cases. Abdominal mass may be felt in a third of cases. The peritoneal fluid is characterized by a [[protein]] concentration > 3 g/dL with < 1.1 g/dL SAAG and [[lymphocyte]] predominance of [[WBC]].  
* [[Ascites]] is present in about half of cases. Abdominal mass may be felt in a third of cases. The peritoneal fluid is characterized by a [[protein]] concentration > 3 g/dL with < 1.1 g/dL SAAG and [[lymphocyte]] predominance of [[WBC]].  
* Definitive diagnosis in 80% of cases is by culture. Most patients presenting acutely are diagnosed only by [[laparotomy]].
* Definitive diagnosis in 80% of cases is by culture. Most patients presenting acutely are diagnosed only by [[laparotomy]].
|
* Combination antituberculosis chemotherapy is preferred in chronic cases.
* Combination antituberculosis chemotherapy is preferred in chronic cases.
|-
|-
Line 53: Line 59:
* Peritonitis is one of the major complications of [[peritoneal dialysis]] & 72.6% occurred within the first six months of peritoneal dialysis.  
* Peritonitis is one of the major complications of [[peritoneal dialysis]] & 72.6% occurred within the first six months of peritoneal dialysis.  
* Historically, [[coagulase-negative staphylococci]] were the most common cause of peritonitis in CAPD, presumably due to touch contamination or infection via the pericatheter route.  
* Historically, [[coagulase-negative staphylococci]] were the most common cause of peritonitis in CAPD, presumably due to touch contamination or infection via the pericatheter route.  
* Majority of peritonitis cases are caused by bacteria(50%-due to [[Gram-positive bacteria|gram positive]] organisms, 15% to [[gram negative]] organisms,20% were culture negative.2% of cases are caused by fungi, mostly [[Candida]] species. Polymicrobial infection in 4%.Exit-site infection was present in 13% and a peritoneal fluid leak in 3 % and M.tuberculosis 0.1%.
*  
* Treatment for [[peritoneal dialysis]]-associated peritonitis consists of antimicrobial therapy, in some cases catheter removal is also warranted.  
* Treatment for [[peritoneal dialysis]]-associated peritonitis consists of antimicrobial therapy, in some cases catheter removal is also warranted.  
* Additional therapies for relapsing or recurrent peritonitis may include fibrinolytic agents and peritoneal lavage. Most episodes of peritoneal dialysis-associated peritonitis resolve with outpatient antibiotic treatment.  
* Additional therapies for relapsing or recurrent peritonitis may include fibrinolytic agents and peritoneal lavage. Most episodes of peritoneal dialysis-associated peritonitis resolve with outpatient antibiotic treatment.  
|
* Majority of peritonitis cases are caused by bacteria(50%-due to [[Gram-positive bacteria|gram positive]] organisms, 15% to [[gram negative]] organisms,20% were culture negative.2% of cases are caused by fungi, mostly [[Candida]] species. Polymicrobial infection in 4%.Exit-site infection was present in 13% and a peritoneal fluid leak in 3 % and M.tuberculosis 0.1%.
|
* Initial empiric antibiotic coverage for peritoneal dialysis-associated peritonitis consists of coverage for [[gram-positive]] organisms (by [[vancomycin]] or a first-generation [[cephalosporin]]) and [[gram-negative]] organisms (by a third-generation [[cephalosporin]] or an [[aminoglycoside]]). Subsequently, the regimen should be adjusted based on culture and sensitivity data. Cure rates are approximately 75%.
* Initial empiric antibiotic coverage for peritoneal dialysis-associated peritonitis consists of coverage for [[gram-positive]] organisms (by [[vancomycin]] or a first-generation [[cephalosporin]]) and [[gram-negative]] organisms (by a third-generation [[cephalosporin]] or an [[aminoglycoside]]). Subsequently, the regimen should be adjusted based on culture and sensitivity data. Cure rates are approximately 75%.
|-
|-
Line 63: Line 72:
* Occurs after perforating, penetrating, inflammatory, infectious, or [[ischemic]] injuries of the GI or GU tracts. Most often follows disruption of a hollow viscus→chemical peritonitis→bacterial peritonitis(polymicrobial, includes [[aerobic]] [[gram negative]] {[[E coli]], [[Klebsiella]], [[Enterobacter]], [[Proteus mirabilis]]} and gram positive { [[Enterococcus]], [[Streptococcus]]} and [[anaerobes]] {[[Bacteroides]], [[clostridia]]}).  
* Occurs after perforating, penetrating, inflammatory, infectious, or [[ischemic]] injuries of the GI or GU tracts. Most often follows disruption of a hollow viscus→chemical peritonitis→bacterial peritonitis(polymicrobial, includes [[aerobic]] [[gram negative]] {[[E coli]], [[Klebsiella]], [[Enterobacter]], [[Proteus mirabilis]]} and gram positive { [[Enterococcus]], [[Streptococcus]]} and [[anaerobes]] {[[Bacteroides]], [[clostridia]]}).  
* Presents with [[abdominal pain]], [[tenderness]], [[guarding]] or rigidity, [[distension]], free peritoneal air, and diminished [[bowel sounds]]. Signs that reflect irritation of the parietal peritoneum resulting [[ileus]]. Systemic findings include [[fever]], [[chills]] or [[rigors]], [[tachycardia]], [[sweating]], [[tachypnea]], [[restlessness]], [[dehydration]], [[oliguria]], [[disorientation]], and, ultimately, refractory [[shock]].  
* Presents with [[abdominal pain]], [[tenderness]], [[guarding]] or rigidity, [[distension]], free peritoneal air, and diminished [[bowel sounds]]. Signs that reflect irritation of the parietal peritoneum resulting [[ileus]]. Systemic findings include [[fever]], [[chills]] or [[rigors]], [[tachycardia]], [[sweating]], [[tachypnea]], [[restlessness]], [[dehydration]], [[oliguria]], [[disorientation]], and, ultimately, refractory [[shock]].  
|
|
* [[Peritoneal lavage]], [[Laparoscopy]] are the treatment of choice.
* [[Peritoneal lavage]], [[Laparoscopy]] are the treatment of choice.
|-
|-
Line 69: Line 80:
* Most often seen in cases of rupture of pathological [[gallbladder]] or [[bile duct]] or [[cholangitic abscess]] or secondary to obstruction of  the biliary tract.
* Most often seen in cases of rupture of pathological [[gallbladder]] or [[bile duct]] or [[cholangitic abscess]] or secondary to obstruction of  the biliary tract.
* Seen in alcoholic patients with [[ascites]].
* Seen in alcoholic patients with [[ascites]].
|
|
|-
|-
| colspan="2" |'''[[Tertiary peritonitis]]'''
| colspan="2" |'''[[Tertiary peritonitis]]'''
Line 76: Line 89:
* Characterized by lack of response to appropriate surgical and [[antibiotic therapy]] due to disturbance in the hosts [[immune response]].  
* Characterized by lack of response to appropriate surgical and [[antibiotic therapy]] due to disturbance in the hosts [[immune response]].  
* Associated with [[Mortality|high mortality]] due to multi organ dysfunction. It presents in a similar way as other [[peritonitis]] but is recognized as an adverse outcome with poor prognosis.
* Associated with [[Mortality|high mortality]] due to multi organ dysfunction. It presents in a similar way as other [[peritonitis]] but is recognized as an adverse outcome with poor prognosis.
|
|
|-
|-
| colspan="2" |'''[[Familial Mediterranean fever (periodic peritonitis, familial paroxysmal polyserositis)]]'''
| colspan="2" |'''[[Familial Mediterranean fever (periodic peritonitis, familial paroxysmal polyserositis)]]'''
Line 83: Line 98:
* Presents with recurrent bouts of [[abdominal pain]] and [[tenderness]] along with [[pleuritic]] or [[joint pain]]. [[Fever]] and [[leukocytosis]] are common.  
* Presents with recurrent bouts of [[abdominal pain]] and [[tenderness]] along with [[pleuritic]] or [[joint pain]]. [[Fever]] and [[leukocytosis]] are common.  
* [[Colchicine]] prevents but does not treat acute attacks.
* [[Colchicine]] prevents but does not treat acute attacks.
|
|
|-
|-
| colspan="2" |'''[[Granulomatous peritonitis]]'''
| colspan="2" |'''[[Granulomatous peritonitis]]'''
Line 91: Line 108:
* The disease is self-liniting.
* The disease is self-liniting.
* Treated with [[corticosteroids]] or [[Anti inflammatory medications|anti-inflammatory agents]].
* Treated with [[corticosteroids]] or [[Anti inflammatory medications|anti-inflammatory agents]].
|
|
|-
|-
| colspan="2" |'''[[Sclerosing encapsulating peritonitis]]'''
| colspan="2" |'''[[Sclerosing encapsulating peritonitis]]'''
Line 96: Line 115:
* Seen in conditions associated with long term [[peritoneal dialysis]], shunts like VP & PV, history of abdominal surgeries, [[liver transplantation]].  
* Seen in conditions associated with long term [[peritoneal dialysis]], shunts like VP & PV, history of abdominal surgeries, [[liver transplantation]].  
* Symptoms include [[nausea]], [[abdominal pain]], [[diarrhea]], [[anorexia]], bloody [[ascites]].
* Symptoms include [[nausea]], [[abdominal pain]], [[diarrhea]], [[anorexia]], bloody [[ascites]].
|
|
|-
|-
| colspan="2" |'''[[Intraperitoneal abscesses]]'''
| colspan="2" |'''[[Intraperitoneal abscesses]]'''
Line 106: Line 127:
* The mortality rate of serious intra-abdominal abscesses is about 30%.
* The mortality rate of serious intra-abdominal abscesses is about 30%.
* Treatment consists of prompt and complete [[CT]] or US guided drainage of the [[abscess]], control of the primary cause, and adjunctive use of effective antibiotics. Open drainage is reserved for abscesses for which percutaneous drainage is inappropriate or unsuccessful.  
* Treatment consists of prompt and complete [[CT]] or US guided drainage of the [[abscess]], control of the primary cause, and adjunctive use of effective antibiotics. Open drainage is reserved for abscesses for which percutaneous drainage is inappropriate or unsuccessful.  
|
|
|-
|-
| colspan="2" |'''[[Peritoneal mesothelioma]]'''
| colspan="2" |'''[[Peritoneal mesothelioma]]'''
Line 115: Line 138:
* Mean time from diagnosis to death is less than 1 year without treatment.   
* Mean time from diagnosis to death is less than 1 year without treatment.   
* At [[laparotomy]] the goal is [[cytoreduction]] with [[excision]]. Debulking surgery and intraperitoneal [[chemotherapy]] improves survival in some cases.
* At [[laparotomy]] the goal is [[cytoreduction]] with [[excision]]. Debulking surgery and intraperitoneal [[chemotherapy]] improves survival in some cases.
|
|
|-
|-
| colspan="2" |'''[[peritoneal carcinomatosis]]'''
| colspan="2" |'''[[peritoneal carcinomatosis]]'''
Line 120: Line 145:
* Associated with a history of [[ovarian]] or GI tract malignancy.
* Associated with a history of [[ovarian]] or GI tract malignancy.
* Symptoms include [[ascites]], [[abdominal pain]], [[nausea]], [[vomiting]].
* Symptoms include [[ascites]], [[abdominal pain]], [[nausea]], [[vomiting]].
|
|
|}
|}



Revision as of 16:38, 24 April 2017

Peritonitis main page

Spontaneous bacterial peritonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spontaneous bacterial peritonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Sandbox: ay On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox: ay

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox: ay

CDC on Sandbox: ay

Sandbox: ay in the news

Blogs on Sandbox: ay

Directions to Hospitals Treating Spontaneous bacterial peritonitis

Risk calculators and risk factors for Sandbox: ay

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]

Overview

Natural history

  • SBP is treatable with antibiotics but early diagnosis and intiation of empiric antibiotics is the most important factor for survival.
  • In a study performed in 2006, Each hour of delay of administration of empiric antibiotics was associated with increased mortality by 7.6% while administration of antibiotics at the first hour of hypotension increased overall survival to 79%.(3)

Complications

The physician should have a high index of suspicion to diagnose SBP early and start empiric antibiotic therapy. The earlier the stage of diagnosis, the better the survival.

Hypotension, hypothermia and shock:

  • With the progression of infection, septicaemia ensues with its classic symptoms and signs. Septicaemia and shock are associated with very bad prognosis.

Altered mental status:

  • Hepatic decompensation in association with the progression of infection make altered mental status more likely to happen. Ammonia levels can be within normal limits or slightly elevated as hepatic decompensation is not the only element leading to the altered mental status.

Paralytic ileus:

  • Peritoneal inflammation can be complicated with paralytiv=c ileus. Paralytic ileus is a very poor prognostic sign with increased mortality rate.

Diarrhea:

  • Diarrhea is common due to associated intestinal bacterial overgrowth.(4)

Prognosis

  • Mortality of SBP remains high. 1-year mortality rate is 30-90 (1), probably due to the advanced liver disease present in the first place.
  • Early admission and prophylactic cephalosporins might have a role in decreasing mortality rate.(2)
Disease Prominent clinical findings Lab tests Tratment
Primary peritonitis Spontaneous bacterial peritonitis
Tuberculous peritonitis
  • Ascites is present in about half of cases. Abdominal mass may be felt in a third of cases. The peritoneal fluid is characterized by a protein concentration > 3 g/dL with < 1.1 g/dL SAAG and lymphocyte predominance of WBC.
  • Definitive diagnosis in 80% of cases is by culture. Most patients presenting acutely are diagnosed only by laparotomy.
  • Combination antituberculosis chemotherapy is preferred in chronic cases.
Continuous Ambulatory Peritoneal Dialysis (CAPD peritonitis)
  • Peritonitis is one of the major complications of peritoneal dialysis & 72.6% occurred within the first six months of peritoneal dialysis.
  • Historically, coagulase-negative staphylococci were the most common cause of peritonitis in CAPD, presumably due to touch contamination or infection via the pericatheter route.
  • Treatment for peritoneal dialysis-associated peritonitis consists of antimicrobial therapy, in some cases catheter removal is also warranted.
  • Additional therapies for relapsing or recurrent peritonitis may include fibrinolytic agents and peritoneal lavage. Most episodes of peritoneal dialysis-associated peritonitis resolve with outpatient antibiotic treatment.
  • Majority of peritonitis cases are caused by bacteria(50%-due to gram positive organisms, 15% to gram negative organisms,20% were culture negative.2% of cases are caused by fungi, mostly Candida species. Polymicrobial infection in 4%.Exit-site infection was present in 13% and a peritoneal fluid leak in 3 % and M.tuberculosis 0.1%.
  • Initial empiric antibiotic coverage for peritoneal dialysis-associated peritonitis consists of coverage for gram-positive organisms (by vancomycin or a first-generation cephalosporin) and gram-negative organisms (by a third-generation cephalosporin or an aminoglycoside). Subsequently, the regimen should be adjusted based on culture and sensitivity data. Cure rates are approximately 75%.
Secondary peritonitis Acute bacterial secondary peritonitis
Biliary peritonitis
Tertiary peritonitis
Familial Mediterranean fever (periodic peritonitis, familial paroxysmal polyserositis)
Granulomatous peritonitis
Sclerosing encapsulating peritonitis
Intraperitoneal abscesses
  • Most common etiologies being Gastrointestinal perforations, postoperative complications, and penetrating injuries.
  • Signs and symptoms depend on the location of the abscess within the peritoneal cavity and the extent of involvement of the surrounding structures.
  • Diagnosis is suspected in any patient with a predisposing condition. In a third of cases it occurs as a sequela of generalized peritonitis.
  • The pathogenic organisms are similar to those responsible for peritonitis, but anaerobic organisms occupy an important role.
  • Diagnosed best by CT scan of the abdomen.
  • The mortality rate of serious intra-abdominal abscesses is about 30%.
  • Treatment consists of prompt and complete CT or US guided drainage of the abscess, control of the primary cause, and adjunctive use of effective antibiotics. Open drainage is reserved for abscesses for which percutaneous drainage is inappropriate or unsuccessful.
Peritoneal mesothelioma
  • Arises from the mesothelium lining the peritoneal cavity.
  • Its incidence is approximately 300-500 new cases being diagnosed in the United States each year. As with pleural mesothelioma, there is an association with an asbestos exposure.
  • Most commonly affects men at the age of 50-69 years. Patients most often present with abdominal pain and later increased abdominal girth and ascites along with anorexia, weight loss and abdominal pain.
  • CT with intravenous contrast typically demonstrates the thickening of the peritoneum. Laparoscopy with tissue biopsy or CT guided tissue biopsy with immunohistochemical staining for calretinin, cytokeratin 5/6, mesothelin, and Wilms tumor 1 antigen remain the gold standard for diagnosis.
  • Mean time from diagnosis to death is less than 1 year without treatment.
  • At laparotomy the goal is cytoreduction with excision. Debulking surgery and intraperitoneal chemotherapy improves survival in some cases.
peritoneal carcinomatosis





References